🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these profiles privately for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and assertions of next-day British shipping. Vendors promote the substance there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.

Some experts stated the popularity for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the service has removed violative content and banned related keywords and query recommendations. The organization said it was committed to keeping the service safe and investing in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found communities with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.

After minutes of entering one group, a vendor shared contact information, where most transactions occur. The vendor provided an guidebook and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, health issues or previous experience.

Product Information and Pricing

Inside these groups, posts show dark colored parcels with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When questioned how long a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service stated it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may subject users to possibly significant medical dangers”.